We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Following a safety review, the FDA has decided to add warnings to the labels of Type 2 diabetes drugs containing saxagliptin and alogliptin due to the increased risk of heart failure in patients with kidney or heart disease. Read More
Days after the European Medicines Agency launched an investigation into Gilead’s Zydelig, the agency’s Pharmacovigilance Risk Assessment Committee now is recommending the drug be taken with antibiotics to prevent pneumonia. Read More
Fresenius Medical Care will shell out $250 million to settle more than 400 lawsuits alleging harm from two of its drugs, GranuFlo and NaturaLyte, under a proposed settlement announced Wednesday. Read More